|
TavistDrug - Tavist The trade name of the product as shown on the labeling.
Dosage -
TABLET; ORAL
Active Ingredient(s) -
Clemastine Fumarate
Strength -
2.68MG
Applicant -
NOVARTIS
New Drug Application (NDA) Number -
017661
Product Number -
001
Therapeutic Equivalence (TE) Code -
Approval Date -
Approved Prior to Jan 1, 1982
Reference Listed Drug (RLD) -
No
Type -
DISCN
Applicant Full Name -
Novartis Pharmaceuticals Corp
Tavist
Tavist Eq 0.5mg Base/5ml Syrup; Oral
Clemastine Fumarate 1.34mg Tablet; Oral Clemastine Fumarate 1.34mg Tablet; Oral Clemastine Fumarate 2.68mg Tablet; Oral Clemastine Fumarate 1.34mg Tablet; Oral Clemastine Fumarate 1.34mg Tablet; Oral Clemastine Fumarate 2.68mg Tablet; Oral Tavist 2.68mg Tablet; Oral Clemastine Fumarate Eq 0.5mg Base/5ml Syrup; Oral Clemastine Fumarate Eq 0.5mg Base/5ml Syrup; Oral NewDrugInformation |